Keywords: Multiple Sclerosis, Multiple Sclerosis, magnetic resonance spectroscopy, ER176 TSPO PET, Thalamus
Motivation: Thalamic innate immune activation in multiple sclerosis (MS) is implicated in neurodegeneration and thalamic atrophy, and potentially accelerating functional decline. Understanding its drivers could aid in developing targeted interventions.
Goal(s): To investigate the links between thalamic innate immune activation and thalamic atrophy, using multimodal imaging metrics to explore innate immune activation and neurodegenerative mechanisms in patients with MS.
Approach: We investigated associations among 1H-MRS, ER176-TSPO-PET biomarkers, and thalamic volume in patients with MS patients and non-MS controls.
Results: In patients with MS, higher mIns/tCr correlated with higher ER176-TSPO-PET SUVR and lower thalamic volume, supporting multimodal imaging for assessing underlying disease processes in MS.
Impact: This study demonstrates the utility of combining MRS, PET, and MRI to explore innate immune activation and neurodegeneration in multiple sclerosis, potentially guiding targeted interventions by offering a comprehensive view of thalamic involvement in disease development and progression.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords